Menu
← Oncology Approval Tracker
FDA DECISION ·
Thyquidity
levothyroxine sodium · Stevens J
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Oral solution approved for TSH suppression alongside surgery and radioiodine in thyrotropin-dependent well-differentiated thyroid cancer; the label also covered hypothyroidism.
LAMPGEN ANALYSIS
Why it matters
Added a liquid option for thyroid hormone suppression in the labeled cancer setting.
What research teams should watch
Verify solution concentration and dosing units and coordinate laboratory follow-up after changing formulations.
PRIMARY RECORDS